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Background: This study was designated to investigate whether extravascular lung water
index (EVLI) is an independent predictor for mortality outcome in patients with severe
sepsis.
Methods: This study prospectively recruited patients with severe sepsis from a medical
intensive care unit (ICU) at a university afﬁliated hospital. In each patient, transpulmonary
thermodilution was used to measure cardiovascular hemodynamics and EVLI via an arterial
catheter placed within 48 h of the patient meeting the criteria for severe sepsis.
Results: In total, 33 patients were studied. EVLI, Acute Physiology and Chronic Health
Evaluation (APACHE) II score, development of acute respiratory distress syndrome, chest
X-ray score, lung injury score, body mass index, prior 24 h ﬂuid balance, albumin, and
white blood cell counts were shown to be predictors of in-hospital survival by a bivariate
analysis. In multinominal logistic regression, EVLI (adjusted odds ratio, 6.21; p ¼ 0.01; 95%
conﬁdence interval, 1.05–1.44) acted as an independent predictor for in-hospital survival.
A cut-off value for EVLI of 10ml/kg had good sensitivity (88.2%) and speciﬁcity (68.7%) by
ROC curve analysis. Medical ICU patients with extremely severe sepsis and a high EVLI
(X10ml/kg) had lower in-hospital survival rate than those with a low EVLI (o10ml/kg)
(15% vs. 67.7%, respectively, po0.001.Elsevier Ltd. All rights reserved.
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lly to this work.
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Extravascular lung water index in severe sepsis 957Conclusions: This investigation suggested that EVLI was an independent predictor for in-
hospital survival in medical ICU patients with severe sepsis. Measurement of EVLI may be
used for risk stratiﬁcation among those patients.
& 2008 Elsevier Ltd. All rights reserved.Introduction
The mortality rates of patients with severe sepsis still
remain unacceptably high, despite signiﬁcant advances in
the treatments for sepsis in the areas of pathophysiology,
epidemiology, diagnosis, monitoring, and therapeutics dur-
ing the past century. Therefore, there have been numerous
attempts to improve outcomes in patients with severe
sepsis. Monitoring the hemodynamic parameters of patients
with severe sepsis and shock is crucial to the management of
these patients.1 Pulmonary arterial catheterization has been
used for hemodynamic monitoring in critically ill patients
with sepsis since 19702; however, its safety and value has
been questioned during the last decade.3
Methods of measuring extravascular lung water (EVLW)
were developed as early as the 1970s,4 but the clinical
application of EVLW measurements using a thermal dye
technique in critically ill patients was only developed in the
1980s.5 Enhanced extravascular lung water, and changes in
pulmonary microvascular pressure (Pmv) and permeability
are notable characteristics of acute lung injury in critically
ill patients.6 Previous work has reported the prognostic
value of EVLW in patients with acute lung injury and the
measurement of EVLW has been demonstrated to be useful
for monitoring septic patients at risk of acute respiratory
distress diseases (ARDS)7; however, few comprehensive
studies have investigated the relationship between EVLW
and clinical outcomes in patients with sepsis.
The pulse-induced contour cardiac output (PiCCO) sys-
tem, which is comparatively a less invasive method than the
traditionally used pulmonary arterial catheter, can measure
EVLW based on transpulmonary thermodilution and contin-
uous pulse contour analysis of cardiac output (CO). Thus,
this system can monitor the hemodynamic status of patients
in the critical care units.8 This study was designated to
investigate whether extravascular lung water index (EVLI) is
an independent predictor for mortality outcome in patients
with severe sepsis.Methods
Patients
The population being investigated was recruited from
patients admitted to a 37-bed medical intensive care unit
(ICU) of a university afﬁliated medical center. The institu-
tional review board approved this study, and a written
informed consent was obtained from all of the patients or
their surrogates. The study was conducted from August 2005
to January 2006. Moreover, the included patients met
standard published criteria9 for severe sepsis without ARDS
upon initial enrollment. All enrolled patients were recruited
consecutively. Patients were followed up until death ordischarge from the hospital. Patients with pregnancy, age
less than 18 years old, altered coagulation, and uncontrolled
malignancy were excluded.
Baseline assessments
All eligible patients were enrolled within 48 h of meeting
the criteria for severe sepsis. Patient-speciﬁc data were
obtained upon enrollment, including demographic data,
past medical history, source of sepsis, and Acute Physiology
and Chronic Health Evaluation (APACHE) II score.10 In
addition, the relevant medical history was collected,
including chronic airway diseases (asthma, chronic airway
obstructive disease, and bronchiectasis), cardiovascular
disease (hypertension, cerebral stroke, coronary disease,
heart failure, and arrhythmia), and chronic renal failure.
Physiology, laboratory, and oxygenation parameters
The physiological parameters, including the previous 24-h
net input/output of ﬂuid balance, shock status, and the
hemodynamic parameters (systemic vascular resistance
index (SVRI), global end-diastolic volume index (GEDI),
intrathoracic blood volume index (ITBI), and cardiac index)
were assessed on patient enrollment. Shock was deﬁned as
systolic blood pressurep90mmHg or mean arterial pressure
p60mmHg. Patient management decisions, including the
type and amount of volume resuscitation, were based on
the discretion of the primary intensive care physician.11
The laboratory serologic data (albumin, white blood cell
counts, and platelet), and oxygenation parameters (PaO2/
FiO2 ratio, lung injury score (LIS) and chest X-ray score)
were listed simultaneously as EVLW was made available by
the PiCCO system.
EVLW and hemodynamic parameters measurement
The EVLW measurement was based on transpulmonary
thermodilution method. This method was recently intro-
duced as part of the PiCCO plus system (Pulsion Medical
System, Munich, Germany), for monitoring severe sepsis
patients being treated in medical ICUs. This method only
used a single indicator (cold saline solution), and demon-
strated a satisfactory correlation with the gravimetric
method.12 A 4-F arterial catheter (PulsiocathPV2014L16;
Pulsion Medical Systems) was positioned in the descending
aorta via the femoral artery using the Seldinger technique.
The femoral arterial catheter and a standard central venous
catheter were connected to pressure transducers, and also
to an integrated bedside monitor (PiCCO; Pulsion Medical
Systems). Following three consecutive central venous
injections of 10ml iced 0.9% saline solution, continuous CO
calibration and EVLW measurements were obtained. CO
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immediately following catheter insertion, and were em-
ployed as the hemodymaic parameters for managing the
patients in the medical ICU with severe sepsis.
The PiCCO catheter system used a single thermal
indicator technique to determine EVLW, CO, and volumetric
parameters. The bolus thermodilution CO was used to
determine patient aortic impedance, which was then used
to calibrate the continuous CO.13 The volume of thermal
indicator that distributed in the ﬂuid volume represented
the intrathoracic thermal volume (ITTV), where ITTV
(ml) ¼ CO the mean transit time of the thermal indica-
tor.14 The pulmonary thermal volume (PTV) was calculated
using PTV (ml) ¼ COT, where T was the exponential
decay time of the thermodilution curve.15 Global end-
diastolic volume (GEDV), and the combined end-diastolic
volumes of four cardiac chambers, were calculated using
ITTVPTV (ml). The intrathoracic blood volume (ITBV)
was obtained from the linear relationship with GEDV,16
where ITBV ¼ 1.25GEDV28.4 (ml). EVLW was equal to
the difference between the thermal indicator distribution of
the chest (ITTV) and the blood volume of the chest (ITBV),14
where EVLW ¼ ITTVITBV (ml).
Parameters were indexed to total body surface area or to
body weight in order to facilitate comparisons. These
indices are described by the following terms: EVLI refers
to EVLW index (EVLI; normal: 3–7ml/kg), ITBI (normal:
850–1000ml/m2), GEDI (normal: 680–800ml/m2), and SVRI
(normal: 1800–2500 dyn s/cm5/m2). Based on previous stu-
dies investigating the range of EVLI measurements in control
patients with no clinical evidence of lung abnormalities,17
elevated EVLI was deﬁned as a value exceeding 10ml/kg.
Another study also determined the cut-off value (10ml/kg)
at which mortality may be inﬂuenced.18 Furthermore,
we selected 10ml/kg as a cut-off value by ROC curve
method analysis, which was highly sensitive (88.2%) and
speciﬁc (68.7%) in predicting in-hospital survival outcome.
Therefore, elevated EVLI was deﬁned as a value exceeding
10ml/kg on the day of undergoing PiCCO system monitoring.
ARDS was considered to be present when the American-
European Consensus Conference (AECC) criteria19 were met
during medical ICU hospitalization after monitoring with the
PiCCO system. The AECC criteria were as follows: acute
onset of hypoxemia (arterial oxygen tension [PaO2]/frac-
tional inspired oxygen [FiO2] ratio o200mmHg) with
bilateral inﬁltrates on a chest radiograph and a pulmonary
artery occlusion pressure p18mmHg, or no evidence
of left atrial hypertension. ARDS severity was assessed
using the lung injury score.20 Additional patient records
included a chest radiograph score (the number of quadrants
with 450% involvement in the alveolar ﬁlling process),
PaO2/FiO2 ratio, and ventilator settings. The development
of ARDS in patients was recorded during their medical ICU
hospitalization.Statistical analysis
All data was expressed as median values and the inter-
quartile range or numeric values (%). Since most continuous
variables were skewed, non-parametric approaches are used
in the study. Quantitative variables between two groupswere compared using the Mann–Whitney test for continuous
variables, and the chi-square test for nominal variables. The
bivariate analyses above were primarily used for the
selection of variables, based on a p-value less than 0.1
due to the consideration of small sample size in this study.
The selected variables were entered into a multinominal
logistic regression analysis to identify the net effects of each
individual factor. The potential problem of colinearity
among several variables, including EVLI, lung injury score,
and CXR was evaluated using Spearman correlation coefﬁ-
cient before running the analysis. Survival was the single
dependent variable. Adjusted odds ratios (OR) and their 95%
conﬁdence intervals (CI) were computed by logistic regres-
sion model analysis to clarify the impact of several
potentially independent prognostic factors (including EVLI)
by controlling for age, gender, and the presence of shock.
The level of statistical signiﬁcance was set at po0.1. Death
from all causes during the hospital stay was taken as the
outcome. Survival days and rate were compared to
two subgroups with different EVLI (EVLIo10ml/kg vs.
EVLIX10ml/kg). Survival curves were traced using the
Kaplan–Meier method, and survival curves were compared
using the log rank test. All analyses were conducted using
SPSS software (version 10.0, SPSS, Chicago, IL) and Prism 4
for Windows (version 4.03, Graphpad Software Inc., San
Diego, CA).Results
This study enrolled 33 patients with severe sepsis in a
medical ICU. Table 1 lists demographic proﬁles (age, gender,
body mass index, and APACH II score), underlying diseases
(chronic lung, cardiovascular and renal disease), and
laboratory serologic data (albumin, platelet, and white
blood cell count). The sources of sepsis included primary
blood stream infection (n ¼ 3), pressure sore infection
(n ¼ 2), and urosepsis (n ¼ 3). All patients with severe
sepsis were initially enrolled without ARDS. The incidence
for the development of ARDS during ICU admission was
33.3% (11/33). The overall in-hospital mortality rate was
51.5% (17/33). The survivors had longer ICU (median,
IQR; 28 (18–48) vs. 3 (1–10), po0.0001) and hospital
(median, IQR; 90 (53–90) vs. 3 (1–10), po0.0001) stay than
the non-survivors.
Bivariate analyses were primarily used for the selection of
variables, based on a p-value less than 0.1 (Table 2). The
selected variables including EVLW index (EVLI), APACHE II
score, BMI, prior 24 h ﬂuid balance, CXR score, lung injury
score, the development of ARDS, white blood cell counts,
and albumin levels were further analyzed by multiple
logistic regression analysis controlling for age, gender, and
the presence of shock. The results are presented in Table 3.
EVLI (adjusted odds ratio, 6.21; p ¼ 0.01; 95% conﬁdence
interval, 1.05–1.44), development of ARDS (adjusted odds
ratio, 5.97; p ¼ 0.02; 95% conﬁdence interval, 0.01–0.48),
lung injury score (adjusted odds ratio, 4.19; p ¼ 0.04; 95%
conﬁdence interval, 1.05–9.34), APACH II score, and CXR
score remained signiﬁcant predictors of in-hospital survival
rate after controlling for other variables. BMI, prior 24 h
ﬂuid balance, white blood cell counts, and albumin levels
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Table 1 Baseline characteristics of all medical ICU
patients with severe sepsis.
Patients, n 33
Baseline characteristics
Age (years) 71 (53.5–77.5)
Male, n (%) 23 (69.7)
APACHE II score 24 (18.5–28)
BMI (kg/m2) 21.05
(18.66–25.96)
Chronic lung disease, n (%) 5 (15.15)
Chronic cardiovascular disease,
n (%)
3 (9.09)
Chronic renal disease, n (%) 8 (24.24)
Source of the sepsis
Respiratory cause, n (%) 25 (75.76)
Primary bloodstream infection,
n (%)
3 (9.09)
Pressure sore infection, n (%) 2 (6.06)
Urosepsis, n (%) 3 (9.09)
Oxygenation
PaO2/FiO2 ratio 177.5
(103.3–236.1)
CXR score 2.0 (1.0–3.0)
Lung injury score 2.0 (1.33–2.84)
Laboratory data
Albumin (g/l) 0.02
(0.017–0.024)
Platelet (109/l) 140 (73–256)
WBC (109/l) 14.4 (8.75–22.5)
Abbreviations: ICU, intensive care unit; APACHE, Acute
Physiology and Chronic Health Evaluation; BMI, body mass
index; CXR, chest X-ray; WBC, white blood cell.
Values are expressed as median and the interquartile range,
or numbers (%), unless otherwise noted.
Extravascular lung water index in severe sepsis 959failed to maintain their prognostic value for the in-hospital
survival status in the adjusted analysis (Table 3).
The proportion of patients surviving with a high
(EVLIX10ml/kg) and a low EVLI (o10ml/kg) were traced
during their hospital stay with the Kaplan–Meier method
(15% vs. 67.7%; log rank test, p ¼ 0.0008; Hazard ratio,
4.71; 95% conﬁdence interval, 1.9–11.7) in Figure 1.
All patients enrolled in our study did not suffer from
severe complications of the PICCO system, such as throm-
bosis formation, wound infection, or bleeding. There was
one patient who suffered from guidewire kinking, and one
patient who suffered from catheter malfunction and had to
change catheters in their artery line.
Discussion
The development of sepsis is associated with increased
capillary permeability. Meanwhile, sepsis-induced altera-
tions of alveolar–capillary barrier function are characterized
by the accumulation of EVLW.21 However, few studies
have prospectively examined EVLW in patients with severe
sepsis. This study showed that the increased EVLW index(EVLIX10ml/kg) associated with severe sepsis will contri-
bute to increased mortality during hospital stay. Moreover,
EVLI, lung injury score, increased incidence of development
of ARDS, lung injury score, and CXR score are independent
predictors of in-hospital survival in medical ICU patients
with severe sepsis.
Martin et al. reported that 27% of their patients who
fulﬁlled the clinical consensus conference criteria for ARDS
had never displayed raised EVLW, and these patients also
exhibited improved survival compared to ARDS patients with
increased EVLW.22 Consistent with previous reports, our
study showed that EVLI (adjust odds ratio, 6.21; p ¼ 0.01;
95% conﬁdence interval, 1.05–1.44), is a more powerfully
independent predictor of in-hospital survival than other
independent variables. By demonstrating that EVLI is an
independent prognostic marker, this study proposed that
EVLI measurements should be performed in patients with
severe sepsis and therapeutic strategies should be consid-
ered in correcting the elevated EVLI. However, further
studies are warranted to investigate the effects of correct-
ing EVLI and the clinical outcome among these patients.
Respiratory failure is one of the most common complica-
tions of severe sepsis, occurring in almost 85% of cases.23
The most severe form of lung failure, acute respiratory
distress syndrome (ARDS), occurs in 40% of patients with
sepsis.18 Recognition of ARDS requires a clinical deﬁnition,
which was standardized in 1994 by the AECC.19 The criteria
involved in this clinical deﬁnition comprise a constellation of
clinical and radiographic ﬁndings. As mentioned above,
subclinical abnormalities in capillary permeability and
subsequently increases in lung water may already be
established in early ARDS; however, the chest X-ray and
blood gas analysis may not display abnormalities. Based on
the present ﬁndings, we suggest that introduction of EVLI
measurements should be started early in the course of
patients with severe sepsis. Nevertheless, further studies
should be conducted to conﬁrm this conclusion.
Optimal monitoring of critically ill ICU patients remains
challenging. Time appears to be crucial for an early
diagnosis to avoid hemodynamic catastrophe, and earlier
therapy appears to improve outcomes in this situation.24
Blood volume is indirectly estimated by measurement of
arterial pressure, heart rate, central venous pressure (CVP),
and pulmonary capillary wedge pressure (PAOP). However,
these variables appear to be unreliable indicators of ITBV
status. Previous research has demonstrated the importance
of EVLW as a prognostic predictor in critically ill patients.18
The present results indicated that EVLW can be rapidly and
safely measured at the bedside using the PiCCO catheter
system, although femoral arterial cannulation is considered
dangerous in patients receiving high doses of vasopressors.
Moreover, this investigation also demonstrated that raised
an EVLI in severe sepsis patients during the early part of
their hospital stay was associated with signiﬁcantly decrease
in-hospital survival.
In our study, EVLI was an independent predictor for in-
hospital survival in medical ICU patients with severe sepsis.
Our study also supports that the more the EVLI is elevated,
the lower the in-hospital survival rate in medical ICU
patients with severe sepsis. There were few complications
from the PiCCO system in this study’s patients, thus EVLI
measurements by PiCCO should be feasible.
ARTICLE IN PRESS
Table 2 Bivariate analysis of predictors of in-hospital survival in medical ICU patients with severe sepsis.
Survivor Non-survivor p-Value
Patients, n 16 17
Baseline characteristics
Age (years) 71 (50–76.5) 71 (53.5–78) NS
Male, n (%) 10 (62.50) 13 (76.47) NS
APACHE II score 22 (18–24.75) 26 (23–31.5) 0.03
BMI (kg/m2) 22.6 (19.6–27.5) 19.1 (17.1–24.4) 0.05
Chronic lung disease, n (%) 2 (12.5) 3 (17.6) NS
Chronic cardiovascular disease, n (%) 0 (0) 3 (17.6) NS
Chronic renal disease, n (%) 4 (25) 4 (23.5) NS
Physiology at enrollment
Prior 24 h ﬂuid balance (ml) 2021 (1092–2565) 2563 (2031–3288) 0.08
Shock (vasopressor requirement), n (%) 12 (75) 16 (94.12) NS
GEDI (ml/m2) 785 (655.5–1021) 810 (704.5–869) NS
ITBI (ml/m2) 950 (819–1260) 1017 (913–1131) NS
SVRI (dyn s/cm5/m2) 1570 (943.5–2184) 1187 (814.5–1947) NS
EVLI (ml/kg) 8.5 (6.25–11.75) 21 (13.5–28.5) 0.001
CI (l/min/m2) 3.5 (2.6–4.4) 3.4 (3.0–4.6) NS
Oxygenation
PaO2/FiO2 ratio 198.5 (117.6–236.6) 150 (72.65–240) NS
CXR score 1.5 (1.0–3.0) 3.0 (2.0–3.5) 0.04
Lung injury score 1.67 (1.33–2.0) 2.67 (1.485–3.3) 0.04
Development of ARDS, n (%) 1 (6.25) 10 (58.82) 0.001
Laboratory data
Albumin (g/l) 0.023 (0.019–0.028) 0.017 (0.015–0.023) 0.03
Platelet (109/l) 173 (79.75–238.5) 95 (56.5–277.5) NS
WBC (109/l) 16.7 (12.2–24.2) 12.8 (5.4–19.4) 0.05
Abbreviations: ICU, intensive care unit; APACHE, Acute Physiology and Chronic Health Evaluation; BMI, body mass index; ARDS, acute
respiratory distress syndrome; GEDI, global end-diastolic volume index; ITBI, intrathoracic blood volume index; SVRI, systemic vascular
resistance index; EVLI, extravascular lung water index; CI, cardiac index; CXR, chest X-ray; WBC, white blood cell.
Values are expressed as median and the interquartile range, or numbers (%), unless otherwise noted.
NS, non-signiﬁcant, p40.1.
p-Value for difference between groupso0.1.
Table 3 Adjusted odds ratio for predictors of in-hospital survival in medical ICU patients with severe sepsis.
Factors Adjusted odds ratioy p-Value 95% conﬁdence interval
EVLI 6.21 0.01 1.05–1.44
Development of ARDS 5.97 0.02 0.01–0.48
Lung injury score 4.19 0.04 1.05–9.34
APACH II score 3.53 0.06 0.99–1.29
CXR score 3.32 0.07 0.96–3.56
WBC 2.52 0.11 0.99–1.01
Albumin 2.37 0.12 0.05–1.42
Prior 24 h ﬂuid balance 1.43 0.23 0.99–1.01
BMI 1.37 0.24 0.78–1.06
Abbreviations: EVLI, extravascular lung water index; ARDS, acute respiratory distress syndrome; APACHE, Acute Physiology and Chronic
Health Evaluation; CXR, chest X-ray; WBC, white blood cell count.
p-Value for difference between groupso0.1.
yAdjusted by age, gender, and the presence of shock in multinominal logistic regression analysis.
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Figure 1 The proportion of patients surviving with a higher
(EVLIX10ml/kg) and a lower EVLI (o10ml/kg) were traced
during their hospital stay with the Kaplan–Meier method (15%
vs. 67.7%; log rank test, p ¼ 0.0008; Hazard ratio, 4.71; 95%
conﬁdence interval, 1.9–11.7). The dashed line represents
patients with a high EVLI; the continuous line represents
patients with a low EVLI.
Extravascular lung water index in severe sepsis 961Conclusion
This study demonstrated severe sepsis patients with
elevated EVLI were more vulnerable to develop mortality
during their hospital stay. Our study advances the notion
that elevated EVLI should be carefully monitored in ICU
patients with sever sepsis. Measurement of EVLI may be used
for risk stratiﬁcation among those patients. However,
further studies are needed to determine that whether
correcting elevated EVLI would affect the clinical outcomes
among ICU patients with severe sepsis.
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